USPTO serial 99181122
+E-PATH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- COOK, RYAN ARMON
- Law office
- TMO LAW OFFICE 135
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with +E-PATH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kelly R Vehec
Kelly R. Vehec Babst Calland Clements and Zomnir, P.C.603 Stanwix StreetTwo Gateway Center, 9th FloorPittsburgh, PA 15222Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable cloud-based software for reporting and extracting pathology data for healthcare providers, life sciences organizations and research institutions | ACTIVE | Jan 1, 2019 |
| 042 | Software as a service (SAAS) services featuring software using artificial intelligence (AI) for automating, analyzing, identifying and reporting in the fields of cancer diagnosis, pathology, and clinical research; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for automating and standardizing pathology report extraction, analysis, and interpretation; (AI) for automating and standardizing pathology report extraction, analysis, and interpretation; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for automating, analyzing and reporting to enhance clinical workflows in oncology and pathology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for providing temporary use of non-downloadable software for enhancing clinical workflows in oncology and pathology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for managing and interpreting pathology data and integrating it with healthcare systems; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for software development and maintenance of software used in the fields of cancer diagnostics and pathology services; Providing medical research information in the field of cancer diagnostics and pathology for medical research purposes; Technical consultancy in the field of the using pathology software in clinical workflows in the field of the medical diagnosis of cancer | ACTIVE | Jan 1, 2019 |
| 044 | Medical analysis services for the diagnosis of cancer; Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Providing medical information in the field of cancer diagnostics and pathology, not for medical research purposes; Medical analysis services relating to the treatment of patients; Providing medical information, consultancy and advisory services; Consultancy in the field of the medical diagnosis of cancer for treatment or diagnostic purposes for patients using pathology software in clinical workflows, for treatment or diagnostic purposes for patients and not for medical research purposes; Medical diagnostic testing, monitoring and reporting services | ACTIVE | Jan 1, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 20, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 2, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 24, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jun 24, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 1, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 1, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 1, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 12, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 12, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 6, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2025 | IUAA | USE AMENDMENT ACCEPTED | — |
| Sep 25, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 21, 2025 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 21, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 13, 2025 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| May 13, 2025 | IUAF | USE AMENDMENT FILED | — |
| May 13, 2025 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| May 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 12, 2025 | NWAP | NEW APPLICATION ENTERED | — |